$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends24/7 Wall Street • 2h
Regeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks Up24/7 Wall Street • 2h
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Zacks Investment Research • Thursday
Looking for income? These dividend stocks have high yields that seem well supported.Market Watch • Thursday
Edison Scientific Announces Agreement with Pfizer to Accelerate Research and DevelopmentBusiness Wire • Thursday
Exploring Analyst Estimates for Pfizer (PFE) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • Thursday
Obesity Pipeline vs. COVID Drag: The Hidden Numbers Deciding Pfizer's Q3 Fate on Nov. 324/7 Wall Street • Thursday
Pfizer Cancer Therapy Shows Extended Progression-Free Survival in Multiple Myeloma PatientsBenzinga • Tuesday
Pfizer's ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple MyelomaBusiness Wire • Tuesday
Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment SettingBusiness Wire • Monday
Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady24/7 Wall Street • Monday
Buy 8 Barron's Big Better Bets (Than T-Bills) Out Of 14 'Safer' October DiviDogsSeeking Alpha • 10/25/26
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026Business Wire • 10/24/26
Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemThe Motley Fool • 10/24/26
Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip24/7 Wall Street • 10/23/26